Platelet Aggregation Inhibitors: Clinical Trials

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	1	Unknown 1
Phase 3	1	Unknown 1

Follow Platelet Aggregation Inhibitors: new trials by email Literature Review of Platelet Aggregation Inhibitors trials Research Report on Platelet Aggregation Inhibitors

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Dapagliflozin Effect in Cognitive Impairment in Stroke Trial Dapagliflozin 10mg Tab, Statins (Cardiovascular Agents), Platelet Antiaggregant - Stroke, Ischemic, Mild Cognitive Impairment	Phase 2 / Phase 3	Unknown	Jaime Daniel Mondragon	270	2020-08-01	2022-10-04

Conditions studied

Cognitive Dysfunction (1)  ·  Dementia, Vascular (1)  ·  Ischemic Stroke (1)  ·  Metabolic Syndrome (1)

Sponsors

Jaime Daniel Mondragon (1)

Countries

Mexico (1)

Results publications

PMID 20204386, PMID 23040716, PMID 28095900, PMID 28950419, PMID 29016744, PMID 29371333, PMID 29446769, PMID 29573529, PMID 31236801, PMID 31248555, PMID 31535829, PMID 32115470, PMID 32144994, PMID 32178931, PMID 32317958, PMID 32352644, PMID 32559474, PMID 32854852, PMID 33030307, PMID 33282811, PMID 33894597, PMID 34813630